| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.132 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
1.132 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
1.132 |
Evidence |
|
| TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
1.132 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
RYR2 |
RYR2: Ryanodine receptor 2 |
1.132 |
Evidence |
|
| TNFSF12 |
TNFSF12, APO3L, UNQ181/PRO207, DR3LG: Tumor necrosis factor ligand superfamily m |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
1.132 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
1.132 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
| ANXA6 |
ANXA6, ANX6: Annexin A6 |
CRKL |
CRKL: Crk-like protein |
1.13 |
Evidence |
|
| NUP50 |
NUP50, NPAP60L, PRO1146: Nucleoporin 50 kDa |
NUP153 |
IPI00514528 |
1.13 |
Evidence |
|
| EIF4A1 |
EIF4A1, DDX2A, EIF4A: Eukaryotic initiation factor 4A-I |
PPIA |
PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A |
1.13 |
Evidence |
|
| RANBP1 |
RANBP1: Ran-specific GTPase-activating protein |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
1.13 |
Evidence |
|
| CAD |
CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase |
MCM6 |
MCM6: DNA replication licensing factor MCM6 |
1.13 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
1.13 |
Evidence |
|